View in EDS HTML Full Text PDF Full Text

Longterm course of neuropsychological symptoms and ME/CFS after SARS-CoV-2-infection: a prospective registry study.

Saved in:
Bibliographic Details
Title: Longterm course of neuropsychological symptoms and ME/CFS after SARS-CoV-2-infection: a prospective registry study.
Authors: Reuken, P. A. (AUTHOR), Besteher, B. (AUTHOR), Finke, K. (AUTHOR), Fischer, A. (AUTHOR), Holl, A. (AUTHOR), Katzer, K. (AUTHOR), Lehmann-Pohl, K. (AUTHOR), Lemhöfer, C. (AUTHOR), Nowka, M. (AUTHOR), Puta, C. (AUTHOR), Walter, M. (AUTHOR), Weißenborn, C. (AUTHOR), Stallmach, A. (AUTHOR)
Source: European Archives of Psychiatry & Clinical Neuroscience. Dec2024, Vol. 274 Issue 8, p1903-1910. 8p.
Subjects: Post-acute COVID-19 syndrome, COVID-19 pandemic, Reporting of diseases, COVID-19, SARS-CoV-2
Abstract: A significant proportion of patients after SARS-CoV-2 infection suffer from long-lasting symptoms. Although many different symptoms are described, the majority of patients complains about neuropsychological symptoms. Additionally, a subgroup of patients fulfills diagnostic criteria for ME/CFS. We analyzed a registry of all patients presenting in the out-patients clinic at a German university center. For patients with more than one visit, changes in reported symptoms from first to second visit were analyzed. A total of 1022 patients were included in the study, 411 of them had more than one visit. 95.5% of the patients reported a polysymptomatic disease. At the first visit 31.3% of the patients fulfilled ME/CFS criteria after a median time of 255 days post infection and and at the second visit after a median of 402 days, 19.4% still suffered from ME/CFS. Self-reported fatigue (83.7–72.7%) and concentration impairment (66.2–57.9%) decreased from first to second visit contrasting non-significant changes in the structured screening. A significant proportion of SARS-CoV-2 survivors presenting with ongoing symptoms present with ME/CFS. Although the proportion of subjective reported symptoms and their severity reduce over time, a significant proportion of patients suffer from long-lasting symptoms necessitating new therapeutic concepts. [ABSTRACT FROM AUTHOR]
Copyright of European Archives of Psychiatry & Clinical Neuroscience is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 180988863
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Longterm course of neuropsychological symptoms and ME/CFS after SARS-CoV-2-infection: a prospective registry study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Reuken%2C+P%2E+A%2E%22">Reuken, P. A.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Besteher%2C+B%2E%22">Besteher, B.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Finke%2C+K%2E%22">Finke, K.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fischer%2C+A%2E%22">Fischer, A.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Holl%2C+A%2E%22">Holl, A.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Katzer%2C+K%2E%22">Katzer, K.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lehmann-Pohl%2C+K%2E%22">Lehmann-Pohl, K.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lemhöfer%2C+C%2E%22">Lemhöfer, C.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nowka%2C+M%2E%22">Nowka, M.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Puta%2C+C%2E%22">Puta, C.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Walter%2C+M%2E%22">Walter, M.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Weißenborn%2C+C%2E%22">Weißenborn, C.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Stallmach%2C+A%2E%22">Stallmach, A.</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22European+Archives+of+Psychiatry+%26+Clinical+Neuroscience%22">European Archives of Psychiatry & Clinical Neuroscience</searchLink>. Dec2024, Vol. 274 Issue 8, p1903-1910. 8p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Post-acute+COVID-19+syndrome%22">Post-acute COVID-19 syndrome</searchLink><br /><searchLink fieldCode="DE" term="%22COVID-19+pandemic%22">COVID-19 pandemic</searchLink><br /><searchLink fieldCode="DE" term="%22Reporting+of+diseases%22">Reporting of diseases</searchLink><br /><searchLink fieldCode="DE" term="%22COVID-19%22">COVID-19</searchLink><br /><searchLink fieldCode="DE" term="%22SARS-CoV-2%22">SARS-CoV-2</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: A significant proportion of patients after SARS-CoV-2 infection suffer from long-lasting symptoms. Although many different symptoms are described, the majority of patients complains about neuropsychological symptoms. Additionally, a subgroup of patients fulfills diagnostic criteria for ME/CFS. We analyzed a registry of all patients presenting in the out-patients clinic at a German university center. For patients with more than one visit, changes in reported symptoms from first to second visit were analyzed. A total of 1022 patients were included in the study, 411 of them had more than one visit. 95.5% of the patients reported a polysymptomatic disease. At the first visit 31.3% of the patients fulfilled ME/CFS criteria after a median time of 255 days post infection and and at the second visit after a median of 402 days, 19.4% still suffered from ME/CFS. Self-reported fatigue (83.7–72.7%) and concentration impairment (66.2–57.9%) decreased from first to second visit contrasting non-significant changes in the structured screening. A significant proportion of SARS-CoV-2 survivors presenting with ongoing symptoms present with ME/CFS. Although the proportion of subjective reported symptoms and their severity reduce over time, a significant proportion of patients suffer from long-lasting symptoms necessitating new therapeutic concepts. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of European Archives of Psychiatry & Clinical Neuroscience is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=180988863
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00406-023-01661-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 8
        StartPage: 1903
    Subjects:
      – SubjectFull: Post-acute COVID-19 syndrome
        Type: general
      – SubjectFull: COVID-19 pandemic
        Type: general
      – SubjectFull: Reporting of diseases
        Type: general
      – SubjectFull: COVID-19
        Type: general
      – SubjectFull: SARS-CoV-2
        Type: general
    Titles:
      – TitleFull: Longterm course of neuropsychological symptoms and ME/CFS after SARS-CoV-2-infection: a prospective registry study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Reuken, P. A.
      – PersonEntity:
          Name:
            NameFull: Besteher, B.
      – PersonEntity:
          Name:
            NameFull: Finke, K.
      – PersonEntity:
          Name:
            NameFull: Fischer, A.
      – PersonEntity:
          Name:
            NameFull: Holl, A.
      – PersonEntity:
          Name:
            NameFull: Katzer, K.
      – PersonEntity:
          Name:
            NameFull: Lehmann-Pohl, K.
      – PersonEntity:
          Name:
            NameFull: Lemhöfer, C.
      – PersonEntity:
          Name:
            NameFull: Nowka, M.
      – PersonEntity:
          Name:
            NameFull: Puta, C.
      – PersonEntity:
          Name:
            NameFull: Walter, M.
      – PersonEntity:
          Name:
            NameFull: Weißenborn, C.
      – PersonEntity:
          Name:
            NameFull: Stallmach, A.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: Dec2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 09401334
          Numbering:
            – Type: volume
              Value: 274
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: European Archives of Psychiatry & Clinical Neuroscience
              Type: main
ResultId 1